Chromosome abnormalities in chronic lymphocytic leukemia revealed by TPA as a mitogen
- 1 September 1983
- journal article
- research article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 10 (1) , 87-93
- https://doi.org/10.1016/0165-4608(83)90109-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Loss of receptor activity for mouse erythrocytes precedes tumour promoter-induced maturation of chronic lymphocytic leukaemia cellsCancer Letters, 1981
- Tumour promoter phorbol-12-myristate-13-acetate induces chromosomal damage via indirect actionNature, 1981
- Chromosome changes in human chronic lymphocytic leukemiaCancer Genetics and Cytogenetics, 1981
- Chromosomes and causation of human cancer and leukemia. XLV. Chromosome patterns in stimulated lymphocytes of chronic lymphocytic leukemiaCancer Genetics and Cytogenetics, 1981
- Proliferation, differentiation, and cytogenetics of chronic leukemic B lymphocytes cultured with mitomycin-treated normal cellsBlood, 1981
- PROLIFERATION, DIFFERENTIATION, AND CYTOGENETICS OF CHRONIC LEUKEMIC B LYMPHOCYTES CULTURED WITH MITOMYCIN-TREATED NORMAL-CELLS1981
- Nonrandom chromosomal aberrations in chronic lymphocytic leukemia revealed by polyclonal B-cell-mitogen stimulationBlood, 1980
- NON-RANDOM CHROMOSOMAL-ABERRATIONS IN CHRONIC LYMPHOCYTIC-LEUKEMIA REVEALED BY POLYCLONAL B-CELL-MITOGEN STIMULATION1980
- Lymphocyte Activation by the Tumor-Promoting Agent 12-O-Tetradecanoylphorbol-13-Acetate (TPA)The Journal of Immunology, 1979
- Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation.The Journal of Experimental Medicine, 1977